Viviane Quirke, The Royal Institution of Great Britain, London, UK
Published online: February 2002
DOI: 10.1038/npg.els.0002828
1905–1998 American pharmacologist who, together with his long-standing collaborator Gertrude Elion, introduced many new drugs, including 6-mercaptopurine and azathioprine, and developed a rational approach to drug design.
Keywords: pharmacologist; Gertrude Elion; Nobel Prize; rational drug design; cancer; autoimmune diseases; nucleic acids; DNA; 6-mercaptopurine (6MP); leukaemia; azathioprine (Imuran); rheumatoid arthritis; Zovirax; AZT
| Further Reading | |
| book George KH (1995) "George H. Hitchings (1905–): American pharmacologist". In: Murray EJ (ed.) Notable Twentieth-Century Scientists, vol. 1. pp. 933–934. Detroit, MI: Gale Group. | |
| Giner-Sorolla A (1988) The excitement of a suspense story, the beauty of a poem: the work of Hitchings and Elion. Trends in Pharmacological Sciences 9: 437–438. | |
| Hitchings GH (1980) Relevance of basic research to pharmaceutical invention. Trends in Pharmacological Sciences 1: 167–168. | |
| book Hitchings GH (1983) "Rational design of anticancer drugs: here, imminent, or illusive?" In: Cheng Y-C (ed.) The Development of Target-Oriented Anticancer Drugs, pp. 227–238. Raven Press, New York. | |
| book Hitchings GH (1998) In: American Men and Women of Science, vol. 3. pp. 874–875. New Providence, R R Bowker. | |
Copyright © 2000-2013 by John Wiley & Sons, Inc., or related companies. All rights reserved.
